Viatris
Update in progressVTRS (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Viatris Inc. is a global healthcare company with operations across North America, Europe, Asia-Pacific and beyond. It has four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris provides prescription brands, generics, complex generics and biosimilars across cardiovascular, CNS, dermatology, diabetes, oncology, respiratory and more. It also offers patient support, diagnostics, education and digital tools, plus distribution through wholesalers, retailers, mail-order and specialty pharmacies. It collaborates with Mapi Pharma, Revance and Theravance Biopharma. Founded 1961, headquartered in Canonsburg, PA.
Company score
- Sentiment
- 0.60
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.35
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.31
- Governance
- -0.71
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.18
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.21
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEOMr. Scott Andrew Smith Ph.D.
- Founded1961
- Employees30,000
- Websitewww.viatris.com
Identifiers
- ISINUS92556V1061
- FIGIBBG00Y4RQNH4
- LEI254900ZZTSW7NL773X71
- CUSIP92556V106
- CIK0001792044